News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Multimodal strategies needed to halt progression of MCI and Alzheimer’s disease
a day ago
byKanas Chan
Early, long-term multimodal interventions are required to halt the progression of mild cognitive impairment (MCI) and Alzheimer’s disease, according to Professor Timothy Kwok of the Division of Geriatrics, Chinese University of Hong Kong (CUHK), who spoke at AIM 2026.
Multimodal strategies needed to halt progression of MCI and Alzheimer’s disease
a day ago
Donanemab delays Alzheimer's disease progression over 3 years
a day ago
byKanas Chan
Donanemab administered for a limited duration continues to slow clinical progression in patients with early symptomatic Alzheimer’s disease (AD) over 3 years, according to Professor Chaur-Jong Hu of the Department of Neurology, Taipei Medical University, who spoke at Advances in Medicine (AIM) 2026.







